Dupixent (dupilumab) is a groundbreaking biologic medication used to treat moderate-to-severe inflammatory conditions such as atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and eosinophilic esophagitis (EoE). As a monoclonal antibody, it works by inhibiting interleukin-4 (IL-4) and interleukin-13 (IL-13), key drivers of inflammation.
For healthcare providers, medical coders, and billing specialists, understanding the HCPCS (Healthcare Common Procedure Coding System) code for Dupixent (J1745) is crucial for accurate claims submission and reimbursement. This guide provides an in-depth look at Dupixent’s HCPCS code, billing best practices, insurance considerations, and clinical applications—ensuring compliance and maximizing revenue cycle efficiency.
HCPCS Code for Dupixent
What is Dupixent?
Dupixent, developed by Regeneron and Sanofi, is an injectable biologic approved by the FDA for multiple conditions:
FDA-Approved Indications
| Condition | FDA Approval Year |
|---|---|
| Moderate-to-Severe Atopic Dermatitis | 2017 |
| Moderate-to-Severe Asthma | 2018 |
| Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) | 2019 |
| Eosinophilic Esophagitis (EoE) | 2022 |
Dupixent is administered via subcutaneous injection, typically every 2-4 weeks, depending on the condition being treated.
Understanding HCPCS Codes
HCPCS (Healthcare Common Procedure Coding System) is a standardized coding system used for billing Medicare, Medicaid, and private insurers. It consists of two levels:
-
Level I (CPT Codes) – Used for physician services (e.g., office visits, surgeries).
-
Level II (HCPCS Codes) – Used for drugs, medical supplies, and durable medical equipment (DME).
Dupixent falls under HCPCS Level II because it is a biologic medication.
HCPCS Code for Dupixent (J1745)
J1745 – Injection, Dupilumab, 1 mg
This code is used for billing Dupixent per milligram (mg) administered.
Key Billing Details
| Parameter | Details |
|---|---|
| HCPCS Code | J1745 |
| Description | Dupilumab, per 1 mg |
| Route of Administration | Subcutaneous (SC) |
| Billing Unit | 1 mg |
| NDC Number | 0023-3347-XX (varies by dosage) |
Reimbursement & Coverage
-
Medicare: Covers Dupixent under Part B if administered in a physician’s office.
-
Medicaid: Varies by state; prior authorization often required.
-
Commercial Insurance: Most plans cover Dupixent but may require step therapy (trying cheaper alternatives first).
Dupixent Dosage & Administration
Dupixent is available in pre-filled syringes and pens in the following strengths:
| Dosage Form | Strength |
|---|---|
| Dupixent Syringe | 200 mg/1.14 mL, 300 mg/2 mL |
| Dupixent Pen | 200 mg/1.14 mL, 300 mg/2 mL |
Typical Dosing Schedule
| Condition | Initial Dose | Maintenance Dose |
|---|---|---|
| Atopic Dermatitis | 600 mg (two 300 mg injections) | 300 mg every 2 weeks |
| Asthma | 400 mg (two 200 mg injections) | 200 mg every 2 weeks or 300 mg every 4 weeks |
| CRSwNP | 600 mg (two 300 mg injections) | 300 mg every 2 weeks |
| Eosinophilic Esophagitis | 300 mg weekly for 12 weeks | 300 mg every 2 weeks |
Insurance Coverage & Prior Authorization
Due to its high cost (~$3,000–$4,000 per month), insurers often require:
✅ Prior Authorization (PA) – Documentation proving medical necessity.
✅ Step Therapy – Trying cheaper alternatives (e.g., topical steroids for eczema) first.
✅ Quantity Limits – Restricting the number of doses per month.
Patient Assistance Programs
-
Dupixent MyWay® – Offers copay assistance and free medication for eligible patients.
-
Sanofi Patient Connection – Provides support for uninsured/underinsured patients.
Common Billing Errors & How to Avoid Them
| Error | Solution |
|---|---|
| Incorrect HCPCS code (using J3490 instead of J1745) | Always verify codes annually via CMS updates. |
| Missing NDC number on claim | Include the 11-digit NDC for accurate processing. |
| Incorrect dosage units | Bill per 1 mg (e.g., 300 mg = 300 units of J1745). |
Dupixent vs. Alternative Treatments
| Treatment | Mechanism | Cost (Monthly) | Efficacy |
|---|---|---|---|
| Dupixent (J1745) | IL-4/IL-13 inhibitor | $3,500 | High |
| Methotrexate | Immunosuppressant | $50 | Moderate |
| Cyclosporine | Calcineurin inhibitor | $200 | Moderate |
| Topical Steroids | Anti-inflammatory | $30 | Low (for severe cases) |
Conclusion
Dupixent (HCPCS J1745) is a revolutionary treatment for chronic inflammatory conditions, but proper coding and billing are essential for reimbursement. Understanding dosage, insurance requirements, and patient assistance programs ensures seamless access to this life-changing therapy. Always verify HCPCS updates and document medical necessity to avoid claim denials.
FAQs
1. What is the HCPCS code for Dupixent?
✅ J1745 (Injection, dupilumab, 1 mg).
2. Does Medicare cover Dupixent?
✅ Yes, under Part B if administered in a clinic.
3. How much does Dupixent cost without insurance?
💰 ~$3,500–$4,000 per month, but patient assistance programs can reduce costs.
4. What diagnoses qualify for Dupixent?
📋 FDA-approved conditions include eczema, asthma, CRSwNP, and eosinophilic esophagitis.
5. How often is Dupixent administered?
⏳ Typically every 2-4 weeks, depending on the condition.
